Page 7 - Zone Trade News Today : Breaking News, Live Updates & Top Stories | Vimarsana

To embed, copy and paste the code into your website or blog: For several years, China has been evaluating changes to its drug approval system to promote drug innovation and patient access to medicines. The year 2020 saw China begin taking steps towards adopting some of those changes. U.S. biopharma companies doing business in China, and those looking to do business in China, should start preparing now for the changes coming in 2021. I. Economic and Trade Agreement Between the United States of America and the People’s Republic of China (Phase One) signed January 15, 2020 (the “Phase One Trade Agreement”) The year 2020 began with China formally committing, in the Phase One Trade Agreement signed with the United States on January 15

United statesDraft provisions of the supreme people courtChina national medical products administrationChina national intellectual property administrationProperty courtChina centerNational people congressTrade agreement betweenPhase oneZone tradePhase one trade agreementThese hatch waxman typeEarly resolution mechanismsDrug patent disputesNational medical products administrationDraft administrative measures